Skip to main content
Journal of Nanobiotechnology logoLink to Journal of Nanobiotechnology
. 2023 Dec 4;21:464. doi: 10.1186/s12951-023-02198-2

Correction: Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation

Yanyan Cao 1,2,#, Tao Sun 1,2,#, Bo Sun 1,2, Guilin Zhang 1,2, Jiayun Liu 1,2, Bin Liang 1,2, Chuansheng Zheng 1,2,, Xuefeng Kan 1,2,
PMCID: PMC10694917  PMID: 38044458

Correction: Journal of Nanobiotechnology (2023) 21:404

10.1186/s12951-023-02170-0

Following publication of the original article [1], the authors identified an error in affiliation 1. The affiliation was incorrectly given as “Department of Radiology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan 430022, China”, but should have been “Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China”.

This error is corrected in the affiliations list below and the original article [1] has been revised.

Footnotes

The online version of the original article can be found at 10.1186/s12951-023-02170-0.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Yanyan Cao and Tao Sun contributed equally to this work

Contributor Information

Chuansheng Zheng, Email: hqzcsxh@sina.com.

Xuefeng Kan, Email: xkliulang1314@163.com.

References

  • 1.Cao Y, Sun T, Sun B, et al. Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation. J Nanobiotechnol 2023;21:404. 10.1186/s12951-023-02170-0. [DOI] [PMC free article] [PubMed]

Articles from Journal of Nanobiotechnology are provided here courtesy of BMC

RESOURCES